Dexmethylphenidate Hydrochloride

盐酸右哌甲酯

Report date: 2026/02/27 20:01:47
NME

Base Information

Drug NameDexmethylphenidate Hydrochloride
Drug Alias Name右哌甲酯D-methylphenidate hydrochlorideDexmethylphenidatumDexmetilfenidatoFocalin XR +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine transporter antagonistsNorepinephrine transporter inhibitors
TargetsNorepinephrine transporterDopamine transporter
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityFatigueNeoplasms
Global Approved IndicationsAttention Deficit Disorder with Hyperactivity
Approved Indications in ChinaAttention Deficit Disorder with Hyperactivity
Original Approved Country/TerritoryUnited States
Original Approved Date2001/11/13
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesSandozIndegene LtdHenan Zhongshuai Pharmaceutical Co Ltd
Inactive CompaniesNovartis Pharma AgTeva Pharmaceuticals Usa IncCelgene Corp +[5] 
Active IndicationsAttention Deficit Disorder with Hyperactivity
Inactive IndicationsFatigueNeoplasms

Other Information

ATC CodeN06BA11
Related LinksWikipediaDrugBankKEGG